282 related articles for article (PubMed ID: 21547159)
1. Integrin targeted delivery of chemotherapeutics.
Chen K; Chen X
Theranostics; 2011 Feb; 1():189-200. PubMed ID: 21547159
[TBL] [Abstract][Full Text] [Related]
2. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
Arosio D; Manzoni L; Corno C; Perego P
Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
[TBL] [Abstract][Full Text] [Related]
3. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.
Liu S
Bioconjug Chem; 2015 Aug; 26(8):1413-38. PubMed ID: 26193072
[TBL] [Abstract][Full Text] [Related]
5. Integrins in drug targeting-RGD templates in toxins.
Lu X; Lu D; Scully MF; Kakkar VV
Curr Pharm Des; 2006; 12(22):2749-69. PubMed ID: 16918409
[TBL] [Abstract][Full Text] [Related]
6. Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.
Garanger E; Boturyn D; Dumy P
Anticancer Agents Med Chem; 2007 Sep; 7(5):552-8. PubMed ID: 17896915
[TBL] [Abstract][Full Text] [Related]
7. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging.
Shi J; Wang F; Liu S
Biophys Rep; 2016; 2(1):1-20. PubMed ID: 27819026
[TBL] [Abstract][Full Text] [Related]
9. PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin α
Liolios C; Sachpekidis C; Kolocouris A; Dimitrakopoulou-Strauss A; Bouziotis P
Molecules; 2021 Mar; 26(6):. PubMed ID: 33810198
[TBL] [Abstract][Full Text] [Related]
10. cRGD functionalised nanocarriers for targeted delivery of bioactives.
Gajbhiye KR; Gajbhiye V; Siddiqui IA; Gajbhiye JM
J Drug Target; 2019 Feb; 27(2):111-124. PubMed ID: 29737883
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the targeted binding of RGD-containing peptide to integrin αVβ3.
Yu YP; Wang Q; Liu YC; Xie Y
Biomaterials; 2014 Feb; 35(5):1667-75. PubMed ID: 24268666
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [
Mohammadi R; Shokri B; Shamshirian D; Zarghi A; Shahhosseini S
Daru; 2020 Jun; 28(1):87-96. PubMed ID: 31845157
[TBL] [Abstract][Full Text] [Related]
13. The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins.
Ludwig BS; Tomassi S; Di Maro S; Di Leva FS; Benge A; Reichart F; Nieberler M; Kühn FE; Kessler H; Marinelli L; Reuning U; Kossatz S
Biomaterials; 2021 Apr; 271():120754. PubMed ID: 33756215
[TBL] [Abstract][Full Text] [Related]
14. The use of one-bead one-compound combinatorial library technology to discover high-affinity αvβ3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle.
Xiao W; Wang Y; Lau EY; Luo J; Yao N; Shi C; Meza L; Tseng H; Maeda Y; Kumaresan P; Liu R; Lightstone FC; Takada Y; Lam KS
Mol Cancer Ther; 2010 Oct; 9(10):2714-23. PubMed ID: 20858725
[TBL] [Abstract][Full Text] [Related]
15. C-glyco"RGD" as α
Vucko T; Pétry N; Dehez F; Lambert A; Monari A; Lakomy C; Lacolley P; Regnault V; Collet C; Karcher G; Pellegrini-Moïse N; Lamandé-Langle S
Bioorg Med Chem; 2019 Sep; 27(18):4101-4109. PubMed ID: 31371219
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
17. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R
Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098
[TBL] [Abstract][Full Text] [Related]
18. Mapping of heparin/heparan sulfate binding sites on αvβ3 integrin by molecular docking.
Ballut L; Sapay N; Chautard E; Imberty A; Ricard-Blum S
J Mol Recognit; 2013 Feb; 26(2):76-85. PubMed ID: 23334915
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.
Liu S
Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846
[TBL] [Abstract][Full Text] [Related]
20. Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials.
Zhao J; Santino F; Giacomini D; Gentilucci L
Biomedicines; 2020 Aug; 8(9):. PubMed ID: 32854363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
